semaglutide vs tesofensine Semaglutide: Phase 2 Data Compared (2026) The Best Peptides for Weight

Patients with any prior NAFLD/NASH, cirrhosis, biliary cirrhosis, HCC, alcoholic liver disease, toxic liver diseases, hepatectomy, liver transplantation, autoimmune hepatitis, or inherited liver diseases were excluded to ensure a causal relationship between treatment exposure and liver outcomes in a time sequence

Patients deserve safe and effective obesity care programs, which should focus on supporting lifestyle change and the clinically appropriate prescribing of FDA-approved obesity medications

FEBS Lett 1992

10.1186/s12891-019-2519-y 167 TsengC.WongM

Serious side effects are rare with compounded semaglutide from licensed 503A pharmacies, but medical evaluation ensures you're on the safest path forward